CORDLIFE GROUP

Out of 11,000 lots done so far more than 10,000 lot are done at $1.16 & above.

Still vested.

Accumulated more today as price soften alittle.

PE now about 22X. Still attractive to buy?

In January I have hightlighted CORDLIFE a potential muti-baggers when it was trading below 60 cents. Lately it's trading as high as $1.185, doubling it prices. It's look like it's finding support and consolidate it gain. At this level it's pricing closer to the rest of the healthcare stocks.

I still like this stock becuse of high profit margin, resilence business, positive cash flow, debt free and the potential growth come from the newly acquire Cord Blood & Cord Tissue Banking Business & Assets in Philippines, Indonesia, India & Hong Kong. Cordlife future looks promising.

Me too... Still heavily vested

Cordlife is still my core stocks.
Similarly like Observer2, I've sold the excess shares bought for good profit.

As long as Cordlife growth & profit margin is on track, I will hold onto it. Even thought it has double it price, it's PE is still the loweest among the health-care stocks. Comparatively Cordlife have better growth potential thenthe other more establish health-care stocks.

Catching the early growth stage of a company are the most rewarding because it's usually the cheaper before it's fully price in but the risk may be higher than the more establishing company.